The Scientist

» drug development and microbiology

Most Recent

image: Doctor Who Blocked Thalidomide Dies

Doctor Who Blocked Thalidomide Dies

By | August 11, 2015

Frances Oldham Kelsey, a physician who halted use of a drug that caused birth defects in babies, has passed away at age 101.

0 Comments

image: Bacterial Enzyme an Antismoking Aid?

Bacterial Enzyme an Antismoking Aid?

By | August 10, 2015

A compound that degrades nicotine before it reaches the brain could serve as a successful smoking cessation therapy, according to an in vitro study.

0 Comments

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

image: Subway Microbiome Study Revised

Subway Microbiome Study Revised

By | August 4, 2015

Researchers tone down their highly publicized study that reported the presence of deadly pathogens on New York City subways.

0 Comments

image: TB Traces

TB Traces

By | August 1, 2015

Take a trip to the mummy museum in Vác, Hungary, to see the human remains that helped researchers learn more about the origins of tuberculosis in Europe.

0 Comments

image: Anthrax Sent in Error to 86 Labs

Anthrax Sent in Error to 86 Labs

By | July 29, 2015

A US Army lab shipped live spores of the deadly bacterium because of improper irradiation protocols, a Department of Defense review has found.

1 Comment

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: EMA Green Lights Malaria Vax

EMA Green Lights Malaria Vax

By | July 27, 2015

The European Medicines Agency endorses the first-ever malaria vaccine for use in children 6 weeks to 17 months old.

0 Comments

image: Antibiotic Resistance Can Boost Bacterial Fitness

Antibiotic Resistance Can Boost Bacterial Fitness

By | July 22, 2015

In some pathogenic bacteria, certain antibiotic resistance–associated mutations may also confer an unexpected growth advantage.

0 Comments

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

Popular Now

  1. New Lyme Disease Test Developed by Summer Student
  2. Caloric Restriction Turns White Fat Brown
  3. The Neanderthal in the Mirror
    Reading Frames The Neanderthal in the Mirror

    Our evolutionary cousin is no longer a blundering caveman. Recent research has painted a picture of a human ancestor with culture, art, and advanced cognitive skills.

  4. How to Build Bioinformatic Pipelines Using Galaxy
RayBiotech